Considering that A-T, as well as many muscular disorders, is a rare disease, there is an urgent need to develop robust, and easy-to-manage cell models that recapitulates cellular dysfunction due to the ATM loss, which would be useful for the investigation of molecular A-T pathogenesis and for drug screening and/or repurposing. This evidence concerns the gene ATM and muscle tissue disorder.